Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Understand what constitutes a good asset allocation for beginners. Enhance your investment strategy with proven insights.
17,719 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Costco blends a lean merchandise line with a robust membership model to outpace rivals. The costco pricing secret tha...
A new tax window in 2026 may allow a retired couple to realize nearly six figures in long-term gains without federal ...
Ramp’s billionaire ignores résumés as the startup emphasizes proven ability over pedigrees, tapping teens who built M...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
When a celebrity moment goes beyond fashion, it becomes a teachable moment for money. This piece breaks down the fina...
A high-net-worth retiree confronts a doubled Medicare Part B premium after a two-year IRMAA lookback on an IRA withdr...
Geopolitical drama around the Strait of Hormuz could ripple through markets and raise inflation. This guide explains ...
A Swedish bitcoin treasury company is launching a new BTC PREF with a 10% yield as investors leave 47.7% of the right...
XRP remains a top topic in 2026 as markets weigh its speed-driven use against regulatory risk and liquidity dynamics....
A retiree discovered that a severance-heavy last paycheck can trigger a Medicare surcharge years later. This story ex...
Retirees earning above $109k face IRMAA, a hidden medicare surcharge that can boost monthly Part B premiums. Experts ...